PATENT CLAIM ANALYSIS

Application Number: 15761053
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "422000"]

Abstract:
The present invention relates to an injectable pre-formulation comprising a low viscosity mixture of: a) at least one neutral diacyl lipid and/or at least one tocopherol; b) at least one phospholipid; c) at least one oxygen containing organic solvent; d) at least one 5HT 3  antagonist; wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. Such compositions may additionally comprise polar solvents and/or further active agents such as opioid agonists and/or antagonists. Methods of treatment, particularly for management of nausea and vomiting such as for post-operative nausea and vomiting and/or therapy induced nausea and vomiting are provided, as well as corresponding uses of the compositions. Administration devices comprising the formulations and kits comprising the devices are also provided.

Claim (Index 13):
A pre-formulation as claimed in any of  claims 1  to  12  wherein component c) comprises or consists of a phosphatidylcholine, preferably soy PC.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 90.0
- Lexical Diversity: 1.64444
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14362517', '14416421', '14362542', '14138704', '11628007']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7729548176493425
- 35 USC 102 Novelty (BERT): 0.53626412231963
- Combined Prediction Score: 0.7492857481163712
- Mean Citation Score: 343.216046
- Max Citation Score: 377.2096
- Similarity Product: 246.85023071289064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test